Patents Assigned to MGI Applied Genomics
  • Use of molindone to treat oppositional defiant disorder and conduct disorder
    Patent number: 6613763
    Abstract: A method for treating the psychiatric disorders known as oppositional defiant disorder and conduct disorder is disclosed. The method comprises the administration of molindone or a pharmaceutically acceptable salt of molindone to a patient suffering from oppositional defiant disorder and/or conduct disorder. The molindone may be either a racemic mixture or the levorotatory form. It may be short acting or in a sustained release, long acting form.
    Type: Grant
    Filed: April 19, 2002
    Date of Patent: September 2, 2003
    Assignee: MGI Applied Genomics
    Inventors: David E. Comings, Bruce Kovacs, Jim MacMurry